1. Home
  2. KN vs RGC Comparison

KN vs RGC Comparison

Compare KN & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knowles Corporation

KN

Knowles Corporation

N/A

Current Price

$31.19

Market Cap

2.8B

ML Signal

N/A

Logo Regencell Bioscience Holdings Limited

RGC

Regencell Bioscience Holdings Limited

N/A

Current Price

$4.19

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KN
RGC
Founded
1946
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.1B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
KN
RGC
Price
$31.19
$4.19
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $44.00
N/A
AVG Volume (30 Days)
★ 754.6K
169.5K
Earning Date
10-22-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 118.94
N/A
EPS
★ 0.58
N/A
Revenue
★ $593,200,000.00
N/A
Revenue This Year
$16.10
N/A
Revenue Next Year
$8.85
N/A
P/E Ratio
$57.41
★ N/A
Revenue Growth
★ 7.17
N/A
52 Week Low
$21.35
$4.29
52 Week High
$42.93
$69.00

Technical Indicators

Market Signals
Indicator
KN
RGC
Relative Strength Index (RSI) 39.62 30.39
Support Level $29.41 N/A
Resistance Level $31.95 $6.40
Average True Range (ATR) 1.45 0.51
MACD 0.03 -0.14
Stochastic Oscillator 17.77 3.64

Price Performance

Historical Comparison
KN
RGC

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: